Main Content

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Cell Reports. Volume 23, Issue 1 p297-312.e12, 3 April 2018 10.1016/j.celrep.2018.03.064

Long noncoding RNAs (lncRNAs) are commonly dysregulated in tumors but only a handful are known to play pathophysiological roles in cancer. We inferred lncRNAs that dysregulate cancer pathways, oncogenes and tumor suppressors (cancer genes) by modeling their effects on the activity of transcription factors, RNA-binding proteins, and microRNAs in 5,185 TCGA tumors and 1,019 ENCODE assays. Our predictions included hundreds of candidate onco- and tumor suppressor lncRNAs (cancer lncRNAs) whose somatic alterations account for the dysregulation of dozens of cancer genes and pathways in each of fourteen tumor contexts. To demonstrate proof of concept, we showed that perturbations targeting OIP5-AS1—an inferred tumor suppressor—and TUG1 and WT1 AS—inferred onco-lncRNAs—dysregulated cancer genes and altered proliferation of breast and gynecological cancer cells. Our analysis indicates that while most lncRNAs are dysregulated in a tumor-specific manner, some, including OIP5-AS1, TUG1, NEAT1, MEG3, and TSIX, synergistically dysregulate cancer pathways in multiple tumor contexts.

Data in the GDC

Supplemental Data

Additional Resources

Instructions for Data Download

Open Access Data

  1. Download the appropriate manifest file from the publication page
  2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API

Controlled Access Data

  1. Download the appropriate manifest file from the publication page
  2. Download a token from the GDC Data Portal
  3. Use the manifest file and token to download data using the GDC DTT or the GDC API

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.